Mineralys Therapeutics, Inc.
MLYS
43 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Jul 21 1:00 AM | David Malcom RodmanChief Medical Officer | Sale | 416 | $26.53 | $11.0K | 51,384(D) | View → |
| Jul 17, 2026 | Jul 17 8:03 PM | Rodman David Malcom | Proposed Sale | 416 | $26.48 | $11.0K | — | View → |
| Jul 13, 2026 | Jul 16 12:58 AM | Jon CongletonDirector, Chief Executive Officer | Sale | 10,700 | $27.24 | $291.4K | 603,621(D) | View → |
| Jul 15, 2026 | Jul 16 12:58 AM | David Malcom RodmanChief Medical Officer | Sale | 6,349 | $26.61 | $169.0K | 51,384(D) | View → |
| Jul 13, 2026 | Jul 16 12:58 AM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $27.58 | $387.7K | 57,733(D) | View → |
| Jul 15, 2026 | Jul 15 8:13 PM | Rodman David Malcom | Proposed Sale | 6,349 | $26.61 | $169.0K | — | View → |
| Jul 13, 2026 | Jul 14 3:08 PM | Rodman David Malcom | Proposed Sale | 14,058 | $27.58 | $387.7K | — | View → |
| Jul 13, 2026 | Jul 13 8:23 PM | Congleton Jon | Proposed Sale | 10,700 | $27.24 | $291.4K | — | View → |
| Jul 13, 2026 | Jul 13 8:22 PM | Rodman David Malcom | Proposed Sale | 14,508 | $26.72 | $387.7K | — | View → |
| Jul 9, 2026 | Jul 10 11:15 PM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $30.30 | $65.8K | 57,733(D) | View → |
| Jul 9, 2026 | Jul 9 8:10 PM | Rodman David Malcom | Proposed Sale | 2,171 | $30.30 | $65.8K | — | View → |
| Jun 30, 2026 | Jun 30 10:41 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 75,000 | $26.14 | $2.0M | 614,321(D) | View → |
| Jun 26, 2026 | Jun 30 10:41 PM | Eric WarrenChief Commercial Officer | Sale | 104,124 | $25.90 | $2.7M | 38,400(D) | View → |
| Jun 30, 2026 | Jun 30 8:20 PM | Congleton Jon | Proposed Sale | 75,000 | $26.14 | $2.0M | — | View → |
| Jun 26, 2026 | Jun 29 1:05 PM | Warren Eric | Proposed Sale | 104,124 | $25.90 | $2.7M | — | View → |
| Jun 17, 2026 | Jun 18 1:18 AM | David Malcom RodmanChief Medical Officer | Sale | 4,584 | $25.00 | $114.6K | 57,095(D) | View → |
| Jun 15, 2026 | Jun 18 1:18 AM | David Malcom RodmanChief Medical Officer | Sale | 9,890 | $23.81 | $235.5K | 57,095(D) | View → |
| Jun 17, 2026 | Jun 18 1:18 AM | Daphne KarydasDirector | Sale | 3,000 | $25.00 | $75.0K | 6,200(D) | View → |
| Jun 17, 2026 | Jun 17 8:20 PM | Rodman David Malcom | Proposed Sale | 4,584 | $25.00 | $114.6K | — | View → |
| Jun 17, 2026 | Jun 17 8:15 PM | Karydas Daphne | Proposed Sale | 3,000 | $25.00 | $75.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 14,058 | $14.25 | 91,667(D) | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,170 | $16.00 | 21,706(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Option Exercise | 3,000 | $12.02 | 41,000(D) | View → |
| Mar 17, 2026 | Mar 17 8:51 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,000(D) | View → |
| Mar 13, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,709 | $14.25 | 95,834(D) | View → |
| Mar 12, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 25,395(D) | View → |
| Mar 9, 2026 | Mar 10 9:48 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 23,876(D) | View → |
| Feb 19, 2026 | Feb 21 12:49 AM | RA CAPITAL MANAGEMENT, L.P.Director | Grant/Award | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Jon CongletonDirector, Chief Executive Officer | Grant/Award | 187,900 | $28.06 | 187,900(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Glenn SblendorioDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Alexander M GoldDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Daphne KarydasDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 0(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Srinivas AkkarajuDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Derek DiroccoDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | David Malcom RodmanChief Medical Officer | Grant/Award | 51,300 | $28.06 | 51,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | Adam Scott LevyCFO and Secretary | Grant/Award | 53,300 | $28.06 | 53,300(D) | View → |
| Feb 17, 2026 | Feb 17 11:56 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,417(D) | View → |